Corrigendum to "Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial" [Clin Microbiol Infect 31 (2025) 274-281].

Wang H, Wang G, Gao Y, Qu L, Wang H, Deng M, Gao H, Li Y, Yang N, Wang B, Liu R, Ma X, Tao Z, Zhang G, Wang Q, Zhao W, Yu Y, Chen L, Liang L, Wang S, Shao L, Yang T, Cao J, Cao Y, Qin X, Zhang J, Ai J, Zhu H, Zhang W

Open source

DOI
10.1016/j.cmi.2025.02.014
Published
2025 May
Container
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cmi.2025.02.014,
  title = {Corrigendum to "Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial" [Clin Microbiol Infect 31 (2025) 274-281].},
  author = {Wang H and Wang G and Gao Y and Qu L and Wang H and Deng M and Gao H and Li Y and Yang N and Wang B and Liu R and Ma X and Tao Z and Zhang G and Wang Q and Zhao W and Yu Y and Chen L and Liang L and Wang S and Shao L and Yang T and Cao J and Cao Y and Qin X and Zhang J and Ai J and Zhu H and Zhang W},
  year = {2025},
  journal = {Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases},
  doi = {10.1016/j.cmi.2025.02.014},
  url = {https://doi.org/10.1016/j.cmi.2025.02.014}
}

RIS

TY  - JOUR
TI  - Corrigendum to "Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial" [Clin Microbiol Infect 31 (2025) 274-281].
AU  - Wang H
AU  - Wang G
AU  - Gao Y
AU  - Qu L
AU  - Wang H
AU  - Deng M
AU  - Gao H
AU  - Li Y
AU  - Yang N
AU  - Wang B
AU  - Liu R
AU  - Ma X
AU  - Tao Z
AU  - Zhang G
AU  - Wang Q
AU  - Zhao W
AU  - Yu Y
AU  - Chen L
AU  - Liang L
AU  - Wang S
AU  - Shao L
AU  - Yang T
AU  - Cao J
AU  - Cao Y
AU  - Qin X
AU  - Zhang J
AU  - Ai J
AU  - Zhu H
AU  - Zhang W
PY  - 2025
JO  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
DO  - 10.1016/j.cmi.2025.02.014
UR  - https://doi.org/10.1016/j.cmi.2025.02.014
ER  - 

APA

H, W., G, W., Y, G., L, Q., H, W., M, D., H, G., Y, L., N, Y., B, W., R, L., X, M., Z, T., G, Z., Q, W., W, Z., Y, Y., L, C., L, L., S, W., L, S., T, Y., J, C., Y, C., X, Q., J, Z., J, A., H, Z., & W, Z. (2025). Corrigendum to "Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial" [Clin Microbiol Infect 31 (2025) 274-281].. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2025.02.014

Source records